[1]
Bradt, N. et al. 2022. A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib. European Journal of Case Reports in Internal Medicine. 9, 10 (Oct. 2022). DOI:https://doi.org/10.12890/2022_003601.